ID   AT131_HUMAN             Reviewed;        1204 AA.
AC   Q9HD20; B3KPJ2; B3KTA7; Q6NT90; Q6ZMG7; Q9H6C6;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=Endoplasmic reticulum transmembrane helix translocase {ECO:0000305};
DE            EC=7.4.2.- {ECO:0000269|PubMed:24392018};
DE   AltName: Full=Endoplasmic reticulum P5A-ATPase {ECO:0000303|PubMed:32973005};
GN   Name=ATP13A1 {ECO:0000303|PubMed:32973005, ECO:0000312|HGNC:HGNC:24215};
GN   Synonyms=ATP13A {ECO:0000312|HGNC:HGNC:24215},
GN   KIAA1825 {ECO:0000303|PubMed:11347906};
GN   ORFNames=CGI-152 {ECO:0000303|Ref.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RA   Chou M.C.-H., Lin W.-C.;
RT   "Identification of novel human genes by comparative proteomics.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C).
RC   TISSUE=Hepatoma, and Kidney epithelium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-1204 (ISOFORM A).
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 844-1204.
RC   TISSUE=Brain, and Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-420.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899 AND SER-905, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=24392018; DOI=10.1371/journal.pone.0085519;
RA   Cohen Y., Megyeri M., Chen O.C., Condomitti G., Riezman I.,
RA   Loizides-Mangold U., Abdul-Sada A., Rimon N., Riezman H., Platt F.M.,
RA   Futerman A.H., Schuldiner M.;
RT   "The yeast p5 type ATPase, spf1, regulates manganese transport into the
RT   endoplasmic reticulum.";
RL   PLoS ONE 8:E85519-E85519(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-899, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF ASP-533.
RX   PubMed=32973005; DOI=10.1126/science.abc5809;
RA   McKenna M.J., Sim S.I., Ordureau A., Wei L., Harper J.W., Shao S., Park E.;
RT   "The endoplasmic reticulum P5A-ATPase is a transmembrane helix dislocase.";
RL   Science 369:0-0(2020).
CC   -!- FUNCTION: Endoplasmic reticulum translocase required to remove
CC       mitochondrial transmembrane proteins mistargeted to the endoplasmic
CC       reticulum (PubMed:32973005). Acts as a dislocase that mediates the ATP-
CC       dependent extraction of mislocalized mitochondrial transmembrane
CC       proteins from the endoplasmic reticulum membrane (PubMed:32973005).
CC       Specifically binds mitochondrial tail-anchored transmembrane proteins:
CC       has an atypically large substrate-binding pocket that recognizes and
CC       binds moderately hydrophobic transmembranes with short hydrophilic
CC       lumenal domains (PubMed:32973005). {ECO:0000269|PubMed:32973005}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[protein]-with a C-terminal TM segment(out) + ATP + H2O =
CC         [protein]-with a C-terminal TM segment(in) + ADP + H(+) + phosphate;
CC         Xref=Rhea:RHEA:66168, Rhea:RHEA-COMP:16963, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:90782, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:32973005};
CC   -!- INTERACTION:
CC       Q9HD20-3; Q92624: APPBP2; NbExp=3; IntAct=EBI-12069500, EBI-743771;
CC       Q9HD20-3; Q13520: AQP6; NbExp=3; IntAct=EBI-12069500, EBI-13059134;
CC       Q9HD20-3; Q8N350-4: CBARP; NbExp=3; IntAct=EBI-12069500, EBI-19051169;
CC       Q9HD20-3; P25025: CXCR2; NbExp=3; IntAct=EBI-12069500, EBI-2835281;
CC       Q9HD20-3; Q15125: EBP; NbExp=3; IntAct=EBI-12069500, EBI-3915253;
CC       Q9HD20-3; Q9GZR5: ELOVL4; NbExp=3; IntAct=EBI-12069500, EBI-18535450;
CC       Q9HD20-3; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-12069500, EBI-18304435;
CC       Q9HD20-3; O15552: FFAR2; NbExp=3; IntAct=EBI-12069500, EBI-2833872;
CC       Q9HD20-3; O15529: GPR42; NbExp=3; IntAct=EBI-12069500, EBI-18076404;
CC       Q9HD20-3; Q8IZD2-3: KMT2E; NbExp=3; IntAct=EBI-12069500, EBI-12900093;
CC       Q9HD20-3; Q9NQG1: MANBAL; NbExp=3; IntAct=EBI-12069500, EBI-3867271;
CC       Q9HD20-3; Q5SR56: MFSD14B; NbExp=3; IntAct=EBI-12069500, EBI-373355;
CC       Q9HD20-3; Q15546: MMD; NbExp=3; IntAct=EBI-12069500, EBI-17873222;
CC       Q9HD20-3; Q6P5S7: RNASEK; NbExp=3; IntAct=EBI-12069500, EBI-18397230;
CC       Q9HD20-3; Q9NY72: SCN3B; NbExp=3; IntAct=EBI-12069500, EBI-17247926;
CC       Q9HD20-3; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-12069500, EBI-18159983;
CC       Q9HD20-3; Q7RTY0: SLC16A13; NbExp=3; IntAct=EBI-12069500, EBI-12243266;
CC       Q9HD20-3; Q9BRI3: SLC30A2; NbExp=3; IntAct=EBI-12069500, EBI-8644112;
CC       Q9HD20-3; Q8IWU4: SLC30A8; NbExp=3; IntAct=EBI-12069500, EBI-10262251;
CC       Q9HD20-3; Q9NQQ7-3: SLC35C2; NbExp=3; IntAct=EBI-12069500, EBI-17295964;
CC       Q9HD20-3; Q5VXT5-2: SYPL2; NbExp=3; IntAct=EBI-12069500, EBI-18196631;
CC       Q9HD20-3; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-12069500, EBI-12947623;
CC       Q9HD20-3; P55061: TMBIM6; NbExp=3; IntAct=EBI-12069500, EBI-1045825;
CC       Q9HD20-3; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-12069500, EBI-8638294;
CC       Q9HD20-3; Q96Q45-2: TMEM237; NbExp=3; IntAct=EBI-12069500, EBI-10982110;
CC       Q9HD20-3; Q86WB7-2: UNC93A; NbExp=3; IntAct=EBI-12069500, EBI-13356252;
CC       Q9HD20-3; Q3ZAQ7: VMA21; NbExp=3; IntAct=EBI-12069500, EBI-1055364;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:24392018}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:24392018}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=A;
CC         IsoId=Q9HD20-1; Sequence=Displayed;
CC       Name=B;
CC         IsoId=Q9HD20-2; Sequence=VSP_000434, VSP_000435;
CC       Name=C;
CC         IsoId=Q9HD20-3; Sequence=VSP_000433;
CC   -!- DOMAIN: Contains a large substrate-binding pocket that recognizes
CC       alpha-helical transmembranes, which alternately faces the endoplasmic
CC       reticulum lumen and cytosol, while remaining accessible to the lipid
CC       bilayer through a lateral opening. The translocase alternates between
CC       two conformations: inward-open (E1) and outward-open (E2) states.
CC       Undergoes a series of conformational changes with ATP-binding,
CC       phosphorylation of the Asp active site and subsequent dephosphorylation
CC       in a Post-Albers cycle (i.e., E1 -> E1-ATP -> E1P-ADP -> E1P -> E2P ->
CC       E2-Pi -> E1). A substrate transmembrane helix with a short,
CC       preferentially positively charged lumenal segment binds to the outward-
CC       open pocket and the E2P-to-E1 transition flips the transmembrane by a
CC       switch from the outward-open to inward-open conformation.
CC       {ECO:0000250|UniProtKB:P39986}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type V subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was initially thought to mediate manganese transport
CC       (PubMed:24392018). However, it was later shown to specifically bind
CC       moderately hydrophobic transmembrane with short hydrophilic lumenal
CC       domains that misinsert into the endoplasmic reticulum
CC       (PubMed:32973005). {ECO:0000269|PubMed:24392018,
CC       ECO:0000269|PubMed:32973005}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH69211.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF288687; AAG01173.1; -; mRNA.
DR   EMBL; AK026044; BAB15334.1; -; mRNA.
DR   EMBL; AK056420; BAG51704.1; -; mRNA.
DR   EMBL; AK095287; BAG53019.1; -; mRNA.
DR   EMBL; AK172778; BAD18759.1; -; mRNA.
DR   EMBL; AB058728; BAB47454.1; -; mRNA.
DR   EMBL; CH471106; EAW84849.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84850.1; -; Genomic_DNA.
DR   EMBL; BC009302; AAH09302.2; -; mRNA.
DR   EMBL; BC069211; AAH69211.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS32970.2; -. [Q9HD20-1]
DR   RefSeq; NP_065143.2; NM_020410.2. [Q9HD20-1]
DR   SMR; Q9HD20; -.
DR   BioGRID; 121393; 84.
DR   IntAct; Q9HD20; 46.
DR   MINT; Q9HD20; -.
DR   STRING; 9606.ENSP00000349877; -.
DR   TCDB; 3.A.3.10.19; the p-type atpase (p-atpase) superfamily.
DR   CarbonylDB; Q9HD20; -.
DR   GlyGen; Q9HD20; 2 sites.
DR   iPTMnet; Q9HD20; -.
DR   PhosphoSitePlus; Q9HD20; -.
DR   SwissPalm; Q9HD20; -.
DR   BioMuta; ATP13A1; -.
DR   DMDM; 18202961; -.
DR   EPD; Q9HD20; -.
DR   jPOST; Q9HD20; -.
DR   MassIVE; Q9HD20; -.
DR   MaxQB; Q9HD20; -.
DR   PaxDb; Q9HD20; -.
DR   PeptideAtlas; Q9HD20; -.
DR   PRIDE; Q9HD20; -.
DR   ProteomicsDB; 81811; -. [Q9HD20-1]
DR   ProteomicsDB; 81812; -. [Q9HD20-2]
DR   ProteomicsDB; 81813; -. [Q9HD20-3]
DR   Antibodypedia; 28529; 81 antibodies.
DR   DNASU; 57130; -.
DR   Ensembl; ENST00000291503; ENSP00000291503; ENSG00000105726. [Q9HD20-2]
DR   Ensembl; ENST00000357324; ENSP00000349877; ENSG00000105726. [Q9HD20-1]
DR   GeneID; 57130; -.
DR   KEGG; hsa:57130; -.
DR   UCSC; uc002nng.4; human. [Q9HD20-1]
DR   CTD; 57130; -.
DR   DisGeNET; 57130; -.
DR   GeneCards; ATP13A1; -.
DR   HGNC; HGNC:24215; ATP13A1.
DR   HPA; ENSG00000105726; Low tissue specificity.
DR   MIM; 619118; gene.
DR   neXtProt; NX_Q9HD20; -.
DR   OpenTargets; ENSG00000105726; -.
DR   PharmGKB; PA134988892; -.
DR   VEuPathDB; HostDB:ENSG00000105726.16; -.
DR   eggNOG; KOG0209; Eukaryota.
DR   GeneTree; ENSGT00550000075064; -.
DR   HOGENOM; CLU_001828_4_1_1; -.
DR   InParanoid; Q9HD20; -.
DR   OMA; RFAPKQK; -.
DR   PhylomeDB; Q9HD20; -.
DR   TreeFam; TF300725; -.
DR   PathwayCommons; Q9HD20; -.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   SIGNOR; Q9HD20; -.
DR   BioGRID-ORCS; 57130; 100 hits in 994 CRISPR screens.
DR   ChiTaRS; ATP13A1; human.
DR   GenomeRNAi; 57130; -.
DR   Pharos; Q9HD20; Tdark.
DR   PRO; PR:Q9HD20; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9HD20; protein.
DR   Bgee; ENSG00000105726; Expressed in small intestine Peyer's patch and 220 other tissues.
DR   ExpressionAtlas; Q9HD20; baseline and differential.
DR   Genevisible; Q9HD20; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IBA:GO_Central.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0071421; P:manganese ion transmembrane transport; IEA:GOC.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.1110.10; -; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR006544; P-type_TPase_V.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   SUPFAM; SSF81653; SSF81653; 1.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   SUPFAM; SSF81665; SSF81665; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 2.
DR   TIGRFAMs; TIGR01657; P-ATPase-V; 1.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Endoplasmic reticulum;
KW   Glycoprotein; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Protein transport; Reference proteome; Translocase;
KW   Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..1204
FT                   /note="Endoplasmic reticulum transmembrane helix
FT                   translocase"
FT                   /id="PRO_0000046421"
FT   TOPO_DOM        2..66
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        67..87
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        88..95
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        96..116
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        117..243
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        244..264
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        265..443
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        444..464
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        465..989
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        990..1010
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1011
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1012..1032
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1033..1051
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1052..1072
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1073..1096
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1097..1117
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1118..1132
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1133..1153
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1154..1166
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1167..1187
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1188..1204
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   NP_BIND         533..535
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   NP_BIND         864..868
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          199..230
FT                   /note="A-domain; part 1"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          295..435
FT                   /note="A-domain; part 2"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          512..541
FT                   /note="P-domain; part 1"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          543..724
FT                   /note="N-domain"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          727..885
FT                   /note="P-domain; part 2"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          886..949
FT                   /note="Arm-like"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   REGION          950..965
FT                   /note="P-domain; part 3"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   ACT_SITE        533
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000305|PubMed:24392018"
FT   METAL           533
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   METAL           535
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   METAL           864
FT                   /note="Magnesium"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   BINDING         626
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y2Q0"
FT   BINDING         684
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   BINDING         749
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P39986"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         899
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         905
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CARBOHYD        287
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        420
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   VAR_SEQ         1..860
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_000433"
FT   VAR_SEQ         1..118
FT                   /note="Missing (in isoform B)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_000434"
FT   VAR_SEQ         119..132
FT                   /note="HWSVHAHCALTCTP -> MEKWEELNSHQPGE (in isoform B)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_000435"
FT   MUTAGEN         533
FT                   /note="D->A: Loss of ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:32973005"
FT   CONFLICT        364
FT                   /note="I -> T (in Ref. 2; BAD18759)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        501
FT                   /note="V -> D (in Ref. 2; BAD18759)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1150
FT                   /note="L -> P (in Ref. 2; BAD18759)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1204 AA;  132955 MW;  9DE335C025FBBA89 CRC64;
     MAAAAAVGNA VPCGARPCGV RPDGQPKPGP QPRALLAAGP ALIANGDELV AAVWPYRRLA
     LLRRLTVLPF AGLLYPAWLG AAAAGCWGWG SSWVQIPEAA LLVLATICLA HALTVLSGHW
     SVHAHCALTC TPEYDPSKAT FVKVVPTPNN GSTELVALHR NEGEDGLEVL SFEFQKIKYS
     YDALEKKQFL PVAFPVGNAF SYYQSNRGFQ EDSEIRAAEK KFGSNKAEMV VPDFSELFKE
     RATAPFFVFQ VFCVGLWCLD EYWYYSVFTL SMLVAFEASL VQQQMRNMSE IRKMGNKPHM
     IQVYRSRKWR PIASDEIVPG DIVSIGRSPQ ENLVPCDVLL LRGRCIVDEA MLTGESVPQM
     KEPIEDLSPD RVLDLQADSR LHVIFGGTKV VQHIPPQKAT TGLKPVDSGC VAYVLRTGFN
     TSQGKLLRTI LFGVKRVTAN NLETFIFILF LLVFAIAAAA YVWIEGTKDP SRNRYKLFLE
     CTLILTSVVP PELPIELSLA VNTSLIALAK LYMYCTEPFR IPFAGKVEVC CFDKTGTLTS
     DSLVVRGVAG LRDGKEVTPV SSIPVETHRA LASCHSLMQL DDGTLVGDPL EKAMLTAVDW
     TLTKDEKVFP RSIKTQGLKI HQRFHFASAL KRMSVLASYE KLGSTDLCYI AAVKGAPETL
     HSMFSQCPPD YHHIHTEISR EGARVLALGY KELGHLTHQQ AREVKREALE CSLKFVGFIV
     VSCPLKADSK AVIREIQNAS HRVVMITGDN PLTACHVAQE LHFIEKAHTL ILQPPSEKGR
     QCEWRSIDGS IVLPLARGSP KALALEYALC LTGDGLAHLQ ATDPQQLLRL IPHVQVFARV
     APKQKEFVIT SLKELGYVTL MCGDGTNDVG ALKHADVGVA LLANAPERVV ERRRRPRDSP
     TLSNSGIRAT SRTAKQRSGL PPSEEQPTSQ RDRLSQVLRD LEDESTPIVK LGDASIAAPF
     TSKLSSIQCI CHVIKQGRCT LVTTLQMFKI LALNALILAY SQSVLYLEGV KFSDFQATLQ
     GLLLAGCFLF ISRSKPLKTL SRERPLPNIF NLYTILTVML QFFVHFLSLV YLYREAQARS
     PEKQEQFVDL YKEFEPSLVN STVYIMAMAM QMATFAINYK GPPFMESLPE NKPLVWSLAV
     SLLAIIGLLL GSSPDFNSQF GLVDIPVEFK LVIAQVLLLD FCLALLADRV LQFFLGTPKL
     KVPS
//
